FGF23 is known to produce cardiac hypertrophy by activating calcineurin with concomitant promotion of protein kinase C (PKC), which can increase late sodium current (INa-Late) in the cardiomyocyte. This evidence concerns the gene PRRT2 and cardiac hypertrophy.